Salisbury Foundation Trust

FOI_6409

Internal Reference Number: FOI_6409

Date Request Received: 21/12/2021 00:00:00

Date Request Replied To: 22/12/2021 00:00:00

This response was sent via: By Email

Request Summary: Analysing the incidence and treatment of Haemophilia A

Request Category: Companies

 
Question Number 1:
How many haemophilia A patients are registered with your centre, and how many of these patients are classified as exhibiting mild, moderate, or severe disease.
 
Answer To Question 1:
Section 38 refusal notice applied
 
Question Number 2:
In the last three months, how many patients have been treated by your haemophilia centre with the following products?
• Advate
• Adynovi
• Elocta
• Esperoct
• Factor Eight Inhibitor Bypass Activity (FEIBA)
• Hemlibra
• NovoEight
• NovoSeven RT
• Obizur
• Refacto AF
 
Answer To Question 2:
Section 38 refusal notice applied
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2022 Salisbury NHS Foundation Trust
Trust Values